Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Allergy Therapeutics plc    AGY   GB00B02LCQ05

ALLERGY THERAPEUTICS PLC

(AGY)
  Report
Delayed Quote. Delayed London Stock Exchange - 01/26 11:35:11 am
19.7 GBX   +1.29%
01/14ALLERGY THERAPEUTICS : Half Year Trading Update 2021 and Notice of Results
AQ
2020ALLERGY THERAPEUTICS : 2020 AGM Poll Vote Results
PU
2020ALLERGY THERAPEUTICS : Notice of Meeting
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
  • The company is in a robust financial situation considering its net cash and margin position.
  • Historically, the company has been releasing figures that are above expectations.
  • As regards fundamentals, the enterprise value to sales ratio is at 1.16 for the current period. Therefore, the company is undervalued.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The tendency within the weekly time frame is positive above the technical support level at 12.25 GBX
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at GBX 21.
  • The company has insufficient levels of profitability.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart
Sector Pharmaceuticals - Other
1st jan.Capitalisation (M$)Investor Rating
ALLERGY THERAPEUTICS PLC18.50%170
JOHNSON & JOHNSON8.32%436 949
ROCHE HOLDING AG3.82%309 894
NOVARTIS AG2.96%220 401
PFIZER INC.1.36%207 217
MERCK & CO., INC.-0.79%205 312
ABBVIE INC.3.13%195 085
ELI LILLY AND COMPANY25.99%192 513
NOVO NORDISK A/S5.39%169 470
AMGEN INC.12.47%149 676
BRISTOL-MYERS SQUIBB COMPAN..3.89%146 500
ASTRAZENECA PLC8.57%141 525
SANOFI3.01%124 175
GLAXOSMITHKLINE PLC5.05%95 723
JIANGSU HENGRUI MEDICINE CO..-0.01%91 311
CHUGAI PHARMACEUTICAL CO., ..2.65%89 482
More Results
Financials
Sales 2021 83,4 M 115 M 115 M
Net income 2021 -4,55 M -6,25 M -6,25 M
Net cash 2021 29,5 M 40,6 M 40,6 M
P/E ratio 2021 -27,2x
Yield 2021 -
Capitalization 126 M 173 M 173 M
EV / Sales 2021 1,16x
EV / Sales 2022 1,22x
Nbr of Employees -
Free-Float 13,8%
Upcoming event on ALLERGY THERAPEUTICS PLC
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes